Prevalence of Left Ventricular Noncompaction in Newborns

Marie F Børresen1,2, Elisabeth Blixenkrone-Møller1,2, Thilde O Kock1,2

  • 1Department of Cardiology, Copenhagen University Hospital Herlev-Gentofte, Denmark (M.F.B., E.B.-M., T.O.K., A.-S.S., R.O.B.V., C.A.P., J.B.N., A.H.C., K.K.I., A.A.R.).

Insights

Left ventricular noncompaction (LVNC) affects 0.076% of neonates and is linked to reduced heart function. This study establishes diagnostic criteria for LVNC in newborns, aiding early detection and management.

Area of Science:

  • Cardiology
  • Neonatal Medicine
  • Pediatric Cardiology

Background:

  • Left ventricular noncompaction (LVNC) is a rare heart muscle disorder characterized by excessive ventricular trabeculations.
  • The exact cause and prevalence of LVNC remain unclear, with ongoing debate about its developmental or acquired nature.
  • Distinguishing normal variations from pathological LVNC is challenging, necessitating population-based studies.

Purpose of the Study:

  • To determine the prevalence of LVNC in a large neonatal cohort.
  • To investigate the association between LVNC and left ventricular (LV) systolic function in neonates.
  • To assess normal noncompact to compact (NC:C) myocardial ratios in healthy newborns.

Main Methods:

  • Echocardiographic data were collected from 25,590 neonates in the Copenhagen Baby Heart Study.
  • LVNC was defined as a noncompact to compact (NC:C) ratio ≥2 in at least one ventricular segment.
  • Neonates with LVNC were matched with controls based on sex, gestational age, and weight.

Main Results:

  • The prevalence of LVNC was found to be 0.076% in the studied neonatal population.
  • Neonates with LVNC exhibited significantly lower LV systolic function compared to matched controls.
  • Normal NC:C ratios in healthy neonates ranged from 0.0 to 0.7, with 99th percentiles up to 1.9.

Conclusions:

  • Neonatal echocardiography identified LVNC in 0.076% of newborns, confirming its rarity.
  • LVNC is associated with impaired LV systolic function in neonates.
  • The NC:C ratio cutoff of ≥2 is supported as a valid diagnostic criterion for LVNC.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
45
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
33
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
37
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
34
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
35
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
53